• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Search Results for: Sickle cell

RHD Genotyping May Enable D-positive RBC Units to be Transfused to Patients with Anti-D

Patients with sickle cell disease (SCD) often require chronic red blood cell exchanges. The American Society for Hematology recommends matching…

November 13, 2024

Intravenous vs Oral Iron for Pregnant Women in Africa

Worldwide, almost 40% of all pregnant women are anemic (hemoglobin < 11 g/dL) with the percentage rising to around 50%…

November 7, 2024

Global Blood Supply Challenges

The World Health Organization (WHO) considers blood an essential medicine, yet nearly two-thirds of countries—primarily low- and middle-income countries (LMIC)—lack…

September 11, 2024

Motivators and Barriers to Donating Blood Among African Americans

In the U.S., blood donations rates are lower among African Americans than the general population.  The National Heart, Lung, and…

April 3, 2024

Platelet-RBC Complexes Associated with RBC Clearance

Platelet-RBC (P-RBC) complexes are associated with several diseases such as sickle cell disease, malaria, and immune thrombocytopenia.  Since diseased RBCs…

February 21, 2024

Low Alloimmunization Risk if No Antibodies Formed during First 20 RBC Transfused Units

RBC transfusions are critical for many patients with sickle cell disease.  Patients are at risk, however, of developing alloantibodies, which…

January 4, 2024

Antigen Density on Surface of RBCs a Factor in RBC Clearance in Incompatible Transfusions

Select patients with chronic anemia and sickle cell disease require recurrent transfusions and are at risk for alloimmunization and potentially…

February 3, 2021

CRISPR-Cas9 Gene Editing and Lentiviral Gene Therapy Hold Promise to Treat Transfusion Dependent β-Globin Hemoglobinopathies

Both transfusion-dependent β-thalassemia (TDT) and sickle cell disease (SCD) are common monogenetic diseases caused by mutations in the gene encoding…

December 15, 2020

RBC Transfusions Reduce Fatigability in Hospitalized Patients with Anemia

In order to determine if red blood cell (RBC) transfusions improve quality of life for hospitalized patients with anemia, researchers…

December 1, 2020

Risk Factors for Hyperhemolysis Syndrome Identified

Hyperhemolysis Syndrome (HS) is a rare, potentially fatal condition characterized by the development of severe anemia after transfusion in which…

October 16, 2019

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Go to Next Page »

Primary Sidebar

Latest News

  • Running Ultra-Long Distances Induces Inflammatory and Oxidative Stress Changes in RBCs

  • Tranexamic Acid for Patients with Hematological Disorders

  • Interventions to Prevent Vasovagal Reactions among Blood Donors

  • Nipocalimab for Severe Hemolytic Disease of the Fetus and Newborn

    Question of the Day

    Copyright © 2026 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley